Blue Heron Biotechnology, Inc. Sustainability Profile
Blue Heron Biotechnology, Inc., headquartered in the United States, is a leading player in the biotechnology industry, specialising in custom DNA synthesis and gene assembly services. Founded in 2000, the company has established itself as a trusted partner for researchers and organisations in various sectors, including pharmaceuticals, agriculture, and synthetic biology. With a commitment to innovation, Blue Heron offers unique products such as high-fidelity DNA constructs and advanced gene editing tools, setting them apart in a competitive market. Their state-of-the-art technology and expertise have garnered recognition, positioning them as a preferred choice for clients seeking precision and reliability in genetic research. As a pioneer in the field, Blue Heron Biotechnology continues to drive advancements that support scientific discovery and development.
DitchCarbon Score
How does Blue Heron Biotechnology, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Blue Heron Biotechnology, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Blue Heron Biotechnology, Inc.'s reported carbon emissions
Blue Heron Biotechnology, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges. As a current subsidiary, Blue Heron Biotechnology may inherit climate commitments and emissions data from its parent organisation; however, no specific details regarding such cascaded data are available. The absence of reported emissions and reduction initiatives suggests that the company may still be in the early stages of developing its climate strategy or may rely on broader corporate family commitments for guidance. In the context of the biotechnology industry, companies are increasingly recognising the importance of sustainability and climate action. Blue Heron Biotechnology's future climate commitments and potential alignment with industry standards will be crucial for its operational sustainability and reputation.
How Carbon Intensive is Blue Heron Biotechnology, Inc.'s Industry?
How Carbon Intensive is Blue Heron Biotechnology, Inc.'s Location?
Blue Heron Biotechnology, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Blue Heron Biotechnology, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
